Mobile

A 24-week, multicenter, international, randomized (1:1), parallel-group, open-label, comparative study of insulin glargine versus liraglutide in insulin-naïve patients with Type 2 diabetes treated wit...

Update Il y a 4 ans
Reference: EUCTR2010-018437-21

A 24-week, multicenter, international, randomized (1:1), parallel-group, open-label, comparative study of insulin glargine versus liraglutide in insulin-naïve patients with Type 2 diabetes treated with oral agents and not adequately controlled, followed by a 24-week extension period with insulin glargine for patients not adequately controlled with liraglutide

Woman and Man

  • | Country :
    • -
  • | organs :
    • -
  • | Specialty :
    • -

Extract

The primary objective of this study is to demonstrate the superiority of insulin glargine over liraglutide in terms of percentage of patients reaching a HbA1c < 7% at the end of the comparative period in Type 2 diabetic patients failing lifestyle management and oral agents.

Inclusion criteria

  • Type 2 diabetes not adequately controlled

Links